HC Wainwright & Co. Maintains Buy on 89bio, Maintains $31 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Ed Arce maintains a Buy rating on 89bio (NASDAQ:ETNB) and keeps the price target at $31.

March 13, 2024 | 1:50 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
89bio receives a maintained Buy rating and a $31 price target from HC Wainwright & Co., indicating a positive outlook.
The maintenance of a Buy rating and a $31 price target by a reputable analyst firm like HC Wainwright & Co. suggests a strong belief in the company's future performance. This endorsement is likely to instill confidence in investors, potentially leading to a positive short-term impact on the stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100